Journal article
Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis
PloS one, Vol.13(8), pp.e0200752-e0200752
2018
DOI: 10.1371/journal.pone.0200752
PMCID: PMC6082653
PMID: 30089166
Abstract
Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS) where pathology is thought to be regulated by autoreactive T cells of the Th1 and Th17 phenotype. In this study we sought to understand the functions of Presenilin 1 (PSEN1) in regulating T cell effector responses in the experimental autoimmune encephalomyelitis (EAE) murine model of MS. PSEN1 is the catalytic subunit of γ-secretase a multimolecular protease that mediates intramembranous proteolysis. γ-secretase is known to regulate several pathways of immune importance. Here we examine the effects of disrupting PSEN1 functions on EAE and T effector differentiation using small molecule inhibitors of γ-secretase (GSI) and T cell-specific conditional knockout mice (PSEN1 cKO). Surprisingly, blocking PSEN1 function by GSI treatment or PSEN1 cKO had little effect on the development or course of MOG35-55-induced EAE. In vivo GSI administration reduced the number of myelin antigen-specific T cells and suppressed Th1 and Th17 differentiation following immunization. In vitro, GSI treatment inhibited Th1 differentiation in neutral but not IL-12 polarizing conditions. Th17 differentiation was also suppressed by the presence of GSI in all conditions and GSI-treated Th17 T cells failed to induce EAE following adoptive transfer. PSEN cKO T cells showed reduced Th1 and Th17 differentiation. We conclude that γ-secretase and PSEN1-dependent signals are involved in T effector responses in vivo and potently regulate T effector differentiation in vitro, however, they are dispensable for EAE.
Details
- Title: Subtitle
- Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis
- Creators
- Matthew Cummings - Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, United States of AmericaAnitha Christy Sigamani Arumanayagam - Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute, Houston, TX, United States of AmericaPicheng Zhao - Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute, Houston, TX, United States of AmericaSunil Kannanganat - Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute, Houston, TX, United States of AmericaOlaf Stuve - Neurology Section, VA North Texas Health Care System, Medical Service, Dallas, TX, United States of AmericaNitin J Karandikar - Department of Pathology, University of Iowa, Iowa City, IA, United States of AmericaTodd N Eagar - Department of Pathology and Genomic Medicine, Houston Methodist Hospital Research Institute, Houston, TX, United States of America
- Resource Type
- Journal article
- Publication Details
- PloS one, Vol.13(8), pp.e0200752-e0200752
- DOI
- 10.1371/journal.pone.0200752
- PMID
- 30089166
- PMCID
- PMC6082653
- NLM abbreviation
- PLoS One
- ISSN
- 1932-6203
- eISSN
- 1932-6203
- Publisher
- Public Library of Science; United States
- Grant note
- R01 NS081237 / NINDS NIH HHS
- Language
- English
- Date published
- 2018
- Academic Unit
- Pathology
- Record Identifier
- 9984047861902771
Metrics
23 Record Views